FDA Inspection
BioMarin Pharmaceutical, Inc.BioMarin Pharmaceutical, Inc. – FDA Inspection, Mar 26, 2025
Record Details
This FDA Inspection record concerns BioMarin Pharmaceutical, Inc., with an inspection on March 26, 2025, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · 82d2a0af-f568-4ba0-b631-24e73e69b55a
Inspection Facts
- Inspection number
- 1268309
- FDA center
- Biologics
Other FDA inspections of BioMarin Pharmaceutical, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| August 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | Not classified | San Francisco District Office | |
| December 14, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 17, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BioMarin Pharmaceutical, Inc.
- FDA Inspection 1251795 - 2024-08-19
- FDA Inspection 1076844 - 2018-11-09
- FDA Inspection 1041169 - 2017-12-14
- FDA Inspection 991276 - 2016-11-04
- FDA Inspection 878935 - 2014-04-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.